Evaluation of the Efficacy and Safety of Rivaroxaban Using a Computer Model for Blood Coagulation
- Resource Type
- Authors
- Anke Sensse; Wolfgang Mueck; Lars Kuepfer; Katrin Coboeken; Hans-Ulrich Siegmund; Wolfgang Weiss; Rolf Burghaus; Joerg Lippert; Thomas Gaub
- Source
- PLOS ONE 6(4), e17626 (2011). doi:10.1371/journal.pone.0017626
PLoS ONE
PLoS ONE, Vol 6, Iss 4, p e17626 (2011)
- Subject
- Benzylamines
medicine.drug_mechanism_of_action
Orthopedic Surgery
lcsh:Medicine
Pharmacology
Biochemistry
Translational Research, Biomedical
Rivaroxaban
lcsh:Science
Multidisciplinary
medicine.diagnostic_test
Anticoagulant
Hematology
Treatment Outcome
Blood Circulation
Medicine
Partial Thromboplastin Time
ddc:500
Coagulation Factors
Research Article
medicine.drug
Partial thromboplastin time
medicine.drug_class
Morpholines
Factor Xa Inhibitor
Thiophenes
Naphthalenes
Models, Biological
Dabigatran
medicine
Humans
Computer Simulation
Enoxaparin
Blood Coagulation
Biology
Prothrombin time
Joint Replacement Surgery
business.industry
lcsh:R
Warfarin
Anticoagulants
Proteins
Computational Biology
Direct thrombin inhibitor
Computer Science
Azetidines
lcsh:Q
Surgery
Propionates
business
- Language
- English
PLoS one 6(4), e17626 (2011). doi:10.1371/journal.pone.0017626
Published by PLoS, Lawrence, Kan.